MDSCs from patients with acute myeloid leukemia (AML) express significantly increased levels of VISTA, and knockdown of VISTA reduces the inhibition of CD8+ T‐cell activity by MDSCs in AML patients [113]. Here, CD8A is linked to acute myeloid leukemia.